Members |
targetComponentId |
Podophyllin 10% |
Podophyllum resin (substance) |
Podophyllin 20% |
Podophyllum resin (substance) |
Podophyllin 40% |
Podophyllum resin (substance) |
Poephila castanotis |
Taeniopygia guttata (organism) |
Poephila gouldiae |
Chloebia gouldiae (organism) |
Poikilotherm |
Kingdom Animalia (organism) |
Poikilovirus |
Suid herpesvirus 1 |
Poison mushroom |
Order Agaricales |
Poisoning by Centruroides sculpturatus |
Poisoning by Centruroides exilicauda |
Poisoning by acetylsalicylic acid |
Poisoning by salicylate |
Poisoning by acidifying agent |
Poisoning |
Poisoning by antirheumatic, NEC |
Poisoning by antirheumatic |
Poisoning by arthropod bite |
Poisoning due to arthropod venom |
Poisoning by drug AND/OR biological |
Poisoning by drug AND/OR medicinal substance |
Poisoning by electrolytic, caloric and water-balanced agent, NEC |
Poisoning by drug AND/OR medicinal substance |
Poisoning by enzyme, NEC |
Poisoning by enzyme |
Poisoning by other psychotropic agent, NEC |
Poisoning by psychotropic agent |
Poisoning by salicylic acid salt |
Poisoning by salicylate |
Poisoning by tranquilizer, NEC |
Poisoning by tranquilizer |
Poisoning by vitamin, NEC |
Poisoning by vitamin |
Poisoning caused by alkalinizing agent |
Poisoning |
Poisoning caused by chloramphenicol group antibiotic |
Poisoning by chloramphenicol |
intoxication mixte |
Poisoning |
Politzerization - action |
Inflation - action |
Polyarticular juvenile rheumatoid arthritis |
Polyarticular juvenile idiopathic arthritis |
Polyarticular juvenile rheumatoid arthritis |
Polyarticular juvenile idiopathic arthritis |
Polyarticular onset juvenile chronic arthritis |
Polyarticular juvenile idiopathic arthritis |
Polyclonal gene rearrangement |
T cell gene rearrangement analysis (procedure) |
Polycythemia neonatorum |
Neonatal polycythemia |
Polycythemia vera |
Polycythemia vera |
Polyethylene glycol 3350 100% powder |
Macrogol 3350 only product |
Polyhydramnios NOS |
Polyhydramnios |
Polyhydramnios NOS |
Polyhydramnios |
Polyhydramnios unspecified |
Polyhydramnios |
Polymethyl methacrylate microspheres 20%/bovine collagen 3.5% injection solution prefilled syringe |
Product containing only bovine collagen and polymethyl methacrylate (medicinal product) |
Polymyxin B sulfate 500,000u powder for injection solution vial |
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial |
Polymyxin b sulfate + trimethoprim sulfate |
Product containing polymyxin B and trimethoprim (medicinal product) |
Polyomavirus group |
Genus Polyomavirus (organism) |
Polyomavirus hominis |
Genus Polyomavirus (organism) |
Polysomatous monster |
Polysomia (disorder) |
Polyvinyl alcohol 1.4% conventional release eye drops |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
Polyvinyl alcohol 1.4% single-use eye drops |
Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) |
Pomfret - dietary |
Pomfret (substance) |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor concentration |
Poor labor contractions |
Uterine inertia |
Poor metabolizer due to cytochrome p450 CYP2C19 variant |
Cytochrome P450 family 2 subfamily C member 19 poor metabolizer (finding) |
Poor metabolizer due to cytochrome p450 CYP2C9 variant |
Cytochrome P450 family 2 subfamily C member 9 poor metabolizer (finding) |
Poor metabolizer due to cytochrome p450 CYP2D6 variant |
Cytochrome P450 family 2 subfamily D member 6 poor metabolizer (finding) |
Porcine factor VIII 700iu powder for injection solution vial |
Product containing only porcine factor VIII in parenteral dose form (medicinal product form) |
Porcupine man |
Ichthyosis hystrix gravior (disorder) |
Porphyria-like reaction caused by poison and/or environmental toxin |
Pseudoporphyria |
Porphyromonas asaccharolyticus |
Porphyromonas asaccharolytica (organism) |
Porphyromonas assacharolytica |
Porphyromonas asaccharolytica (organism) |
Porphyromonas endodontalis |
Porphyromonas endodontalis |
Porpoise distemper virus |
Cetacean morbillivirus (organism) |
Portable electroencephalogram awake and asleep with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and asleep with stimulation |
Portable electroencephalogram awake and drowsy with hyperventilation and/or photic stimulation |
Portable electroencephalogram awake and drowsy with stimulation |
Portocath injection |
Implantable venous access port injection |
Position of male urethral meatus |
Position of male external urethral orifice (observable entity) |
imagerie du myocarde au repos à l'aide de la tomographie par émission de positons utilisant le rubidium 81 |
Positron emission tomography myocardial rest imaging using rubidium-82 (procedure) |
imagerie du myocarde à l'effort à l'aide de la tomographie par émission de positons utilisant le rubidium 81 |
Positron emission tomography myocardial stress imaging using rubidium-82 (procedure) |
Positron emission tomography using rubidium 81 with computed tomography myocardial rest imaging |
Positron emission tomography with computed tomography myocardial rest imaging using rubidium-82 (procedure) |
Positron emission tomography using rubidium 81 with computed tomography myocardial stress imaging |
Positron emission tomography with computed tomography myocardial stress imaging using rubidium-82 (procedure) |
grossesse possible |
Possible pregnancy |
Post transplant lymphoproliferative disorder, no International Classification of Diseases for Oncology subtype |
Post-transplantation lymphoproliferation (morphologic abnormality) |
Post-delivery acute renal failure NOS |
Postpartum acute renal failure (disorder) |
Post-delivery acute renal failure unspecified |
Postpartum acute renal failure (disorder) |
Post-translational genetic ribonucleic acid processing |
Post-transcriptional genetic ribonucleic acid processing (finding) |
Postcardiac injury pericarditis |
Post-cardiac injury syndrome (disorder) |
Postcardiotomy syndrome |
Post-pericardiotomy syndrome |
Postcardiotomy syndrome |
Post-pericardiotomy syndrome |
Postcardiotomy syndrome |
Post-pericardiotomy syndrome |
Postcoital bleeding |
Postcoital bleeding |
Posterior cervical cord injury without bony injury, C5-7 |
Posterior cervical spinal cord injury without spinal bone injury, C5-7 (disorder) |
Posterior cervical cord injury, without bony injury, C1-4 |
Posterior cervical spinal cord injury, without spinal bone injury, C1-4 (disorder) |
Posterior cervical flap |
Flap (substance) |
Posterior chest flap |
Flap (substance) |
Posterior interosseous fasciocutaneous flap plus radius |
Osteofasciocutaneous flap (substance) |
Posterior ligament of iris |
Trabecular meshwork structure |
Posterior thigh flap |
Flap (substance) |
Posterior tibial flap |
Posterior tibial artery flap |
Postmortem blood drug level increased |
Blood substance level above reference range |
Postnatal Anti-D prophylaxis refused |
Administration of human anti-D immunoglobulin declined |
Postoperative cellulitis of surgical wound |
Postoperative wound cellulitis |
interventions postopératoires |
Postoperative procedure (procedure) |
Postoperative pulmonary edema |
Postoperative pulmonary edema |
Postpartum coagulation defects NOS |
Postpartum coagulation defects |
Postpartum coagulation defects unspecified |
Postpartum coagulation defects |
Postprocedural intra-abdominal sepsis |
Intra-abdominal infection following surgical procedure |
Posttraumatic wound infection, NEC |
Post-traumatic wound infection |
Postural proteinuria |
Orthostatic proteinuria (finding) |
Potassium 6.5mmol effervescent tablet |
Potassium only product in oral dose form |
allergie au potassium |
Propensity to adverse reaction to potassium (finding) |
Potassium bicarbonate+citric acid 1.39g/1.14g soluble tablet |
Citric acid and potassium bicarbonate only product in oral dose form |
Potassium chloride 10% injection solution ampule |
Product containing precisely potassium chloride 100 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Potassium chloride 10meq m/r tablet |
Product containing only potassium chloride in oral dose form (medicinal product form) |
Potassium chloride 10meq prolonged-release oral tablet |
Product containing only potassium chloride in oral dose form (medicinal product form) |
Potassium chloride 10mmol/dextrose 4%/saline 0.18% infusion solution 500mL bag |
Anhydrous glucose 40 mg/mL and potassium chloride 1.5 mg/mL and sodium chloride 1.8 mg/mL solution for injection |
Potassium chloride 10mmol/dextrose 5%/saline 0.45% infusion solution 500mL bag |
Product containing precisely anhydrous glucose 50 milligram/1 milliliter and potassium chloride 1.5 milligram/1 milliliter and sodium chloride 4.5 milligram/1 milliliter conventional release solution for injection (clinical drug) |